MOK inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of MOK, a serine/threonine protein kinase that plays a role in regulating various cellular signaling pathways. MOK, short for MAPK/MAK/MRK-overlapping kinase, is part of the larger MAP kinase family and is involved in modulating key processes such as cell proliferation, differentiation, and stress responses. Kinases like MOK function by phosphorylating specific substrates, thereby regulating their activity and influencing downstream signaling cascades. Although the exact biological roles of MOK are not fully elucidated, its involvement in signal transduction suggests that it plays a role in maintaining cellular homeostasis and responding to external stimuli. By inhibiting MOK, researchers can disrupt these signaling networks, providing a tool to study the specific contributions of MOK to cellular signaling and its broader impact on physiological processes.
In research settings, MOK inhibitors are valuable for exploring the molecular mechanisms by which MOK regulates signaling pathways and how these pathways influence cellular function. By blocking MOK activity, scientists can investigate how the inhibition affects the phosphorylation status of target proteins and the downstream signaling pathways they regulate. This inhibition allows researchers to study the consequences on cellular processes such as cell cycle progression, differentiation, and apoptosis, where kinase-mediated signaling is critical. Additionally, MOK inhibitors provide insights into the interactions between MOK and other kinases or signaling molecules, helping to elucidate the complex networks that govern cellular responses to internal and external cues. Through these studies, the use of MOK inhibitors enhances our understanding of the regulation of kinase activity, the role of MOK in cellular signaling, and the broader implications for cellular homeostasis and adaptation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound may inhibit DNA methyltransferases, leading to demethylation and potentially suppressing MOK gene expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide might decrease the transcription of various genes, possibly including MOK. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
This kinase inhibitor could indirectly affect MOK expression by inhibiting pathways that upregulate MOK expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, which is upstream of many signaling pathways, possibly leading to reduced expression of MOK. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
By inhibiting MEK, which is upstream of ERK, PD98059 may indirectly inhibit MOK expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
This inhibitor of JNK might modulate transcription factors that control MOK gene expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that could disrupt upstream signaling, leading to reduced MOK expression. | ||||||
Silybin | 22888-70-6 | sc-202812 sc-202812A sc-202812B sc-202812C | 1 g 5 g 10 g 50 g | $55.00 $114.00 $206.00 $714.00 | 6 | |
Silibinin can modulate signal transduction pathways, potentially decreasing the transcription of the MOK gene. | ||||||